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Introduction
Treatment of specific patterns of symptomatic hydroce-
phalus in the adult patient may be accomplished with
endoscopic third ventriculostomy (ETV) as an alterna-
tive to insertion of a ventriculoperitoneal (VP) shunt or
when VP shunt failure occurs. Treatment of hydroce-
phalus with a VP shunt, while effective, is associated
with a significant shunt failure rate that results in VP
shunt revision surgery. This review examines a single
center experience with ETV to treat hydrocephalus in
symptomatic adult patients.
Methods
Adult patients (>/=18 years) with a diagnosis of hydro-
cephalus who were treated with ETV in Calgary between
January 1994 and July 2014 were reviewed using a clinic
database and registry. All patients were treated by one
neurosurgeon.
Results
163 adult patients with symptomatic hydrocephalus trea-
ted with ETV were identified (male=92; female=71). Mean
age at the time of ETV was 46 years (range 18-83 years).
112 underwent ETV as a primary treatment and 51
patients underwent treatment after presenting with VP
shunt failure (secondary ETV). 113/163 patients had a
diagnosis of aqueductal stenosis, 22/163 had a diagnosis of
tumor. Mean followup was 8.2 years (range 0.3-18.4
years). Symptoms in 149/163 (91.4%) of ETV patients
were better or unchanged at last followup. 104/118
(88.1%) of primary ETV patients were shunt free at last
followup. 39/45 (86.7%) of secondary ETV patients were
shunt free at last followup.
Conclusions
Endoscopic (ETV) treatment of hydrocephalus is an
effective longterm treatment in a select population adult
patients with hydrocephalus. Outcome/results are simi-
lar for patients where ETV is used as either a primary
or secondary treatment. 87-88% of patients remain
shunt free with a mean 8.2 years of followup.
Learning objectives
1) To understand the role of ETV for primary treat-
ment of hydrocephalus in the adult patient.
2) To understand the role of ETV for secondary treat-
ment of hydrocephalus in the adult patient.
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